Late cellular rejection in paediatric liver transplantation: aetiology and outcome
- PMID: 11792983
- DOI: 10.1097/00007890-200201150-00015
Late cellular rejection in paediatric liver transplantation: aetiology and outcome
Abstract
Background: Acute cellular rejection, though mostly encountered during the first 3 months after liver transplant, may occur later on. Clinical features and outcome of children experiencing late cellular rejection (LCR) have not been described to date.
Patients and methods: A total of 20 children who developed acute rejection 6 months or more after liver transplant were studied for history of early rejection, levels of immunosuppression, causes of low immunosuppression, viral infections, signs of autoimmunity, and HLA mismatch. All liver biopsies were reviewed. Fifteen patients with no history of LCR were randomly selected as controls.
Results: Of 20 children 5 were appropriately immunosuppressed, although 15 were not. Causes of low immunosuppression were: unknown (seven), poor compliance (three), posttransplant lymphoproliferative disease, (two), hepatocellular carcinoma recurrence (one), tuberculosis (one), gastroenteritis (one). Of 20 patients early rejection occurred in 13 and cytomegalovirus infection in 5. At last follow-up 10 children have persistent graft dysfunction, of whom 5 have progressed to de novo autoimmune hepatitis, 2 to chronic rejection, one has persistent graft dysfunction with recurrent cytomegalovirus activation, one has hepatic artery thrombosis and one is likely to have persistent poor compliance. None of the 15 controls developed de novo autoimmune hepatitis or any other form of persistent graft dysfunction at the time of last follow-up.
Conclusion: Late cellular rejection in children is usually due to low or decreased immunosuppression and is associated with long-term complications. Prompt intervention to correct inadequate immunosuppression and careful follow-up of the other patients to identify other treatable conditions is essential.
Similar articles
-
CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.Liver Transpl. 2002 Dec;8(12):1138-46. doi: 10.1053/jlts.2002.36732. Liver Transpl. 2002. PMID: 12474153
-
Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.Ann Surg. 1999 Jun;229(6):824-31; discussion 831-3. doi: 10.1097/00000658-199906000-00009. Ann Surg. 1999. PMID: 10363896 Free PMC article.
-
Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation.Liver Transpl. 2005 Dec;11(12):1597-602. doi: 10.1002/lt.20523. Liver Transpl. 2005. PMID: 16315314
-
Conversion from cyclosporin to tacrolimus in paediatric liver transplant recipients.Paediatr Drugs. 2001;3(9):661-72. doi: 10.2165/00128072-200103090-00004. Paediatr Drugs. 2001. PMID: 11688597 Review.
-
What does the long-term liver allograft look like for the pediatric recipient?Liver Transpl. 2009 Nov;15 Suppl 2:S19-24. doi: 10.1002/lt.21902. Liver Transpl. 2009. PMID: 19877293 Review.
Cited by
-
Population pharmacokinetic analysis of tacrolimus in the first year after pediatric liver transplantation.Eur J Clin Pharmacol. 2013 Aug;69(8):1533-42. doi: 10.1007/s00228-013-1501-0. Epub 2013 Apr 16. Eur J Clin Pharmacol. 2013. PMID: 23588560
-
Severe acute allograft rejection 22 years after liver transplantation.Can Liver J. 2024 Dec 19;7(4):500-504. doi: 10.3138/canlivj-2024-0004. eCollection 2024 Dec. Can Liver J. 2024. PMID: 40677534 Free PMC article.
-
Is there a role for cyclophilin inhibitors in the management of primary biliary cirrhosis?Viruses. 2013 Jan 24;5(2):423-38. doi: 10.3390/v5020423. Viruses. 2013. PMID: 23348060 Free PMC article. Review.
-
Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management.Hepatol Int. 2010 May 19;4(2):475-93. doi: 10.1007/s12072-010-9183-5. Hepatol Int. 2010. PMID: 20827405 Free PMC article.
-
Management of acute rejection in paediatric liver transplantation.Paediatr Drugs. 2013 Dec;15(6):459-71. doi: 10.1007/s40272-013-0034-4. Paediatr Drugs. 2013. PMID: 23925711 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials